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ABSTRACT 
Objective: Healthcare associated infection (HAI) surveillance programs 
are critical for infection prevention. Australia does not have a 
comprehensive national HAI surveillance program. The purpose of this 
paper is to provide an overview of established international and 
Australian state wide HAI surveillance programs and recommend a 
pathway for the development of a national HAI surveillance program in 
Australia.  
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Methods: Examine existing HAI surveillance programs through a) 
literature review, b) review of HAI surveillance program 
documentation such as websites, surveillance manuals and data reports 
and c) direct contact with program representatives. 
Results: Evidence from international programs demonstrates national 
HAI surveillance reduces the incidence of HAIs. However, the current 
status of HAI surveillance activity in Australian States is disparate, 
variation between programs is not well understood, and the quality of 
data currently used to compose national HAI rates is uncertain. 
Conclusions: There is a need to develop a well structured, evidence 
based national HAI program in Australia to meet the increasing demand 
for validated reliable national HAI data.  Such a program could be 
leveraged off the work of existing Australian and international 
programs. 
 
  
1. What is known about the topic? 
 There is a large volume of literature demonstrating the effectiveness 
of national HAI surveillance programs in reducing the incidence of 
HAIs. Whilst some of the larger states of Australia have individual 
programs, a formalised national program does not exist. A well-
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structured national HAI program in Australia would improve the 
understanding of the epidemiology of HAIs in Australia and provide 
high quality data for both performance monitoring and to ensure HAI 
prevention interventions are targeted appropriately. 
2. What does this paper add? 
This papers reviews well established international HAI surveillance 
programs and highlights the benefits and limitations of these programs, 
whilst identifying the gaps that currently exist in Australia. The paper 
then maps out a pathway towards the development of a national 
program. 
3. What are the implications for practitioners? 
 This paper will act as a guide for future research and policy activities 
required for the establishment of a national HAI surveillance program 
in Australia.  
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Introduction 
A healthcare associated infection (HAI) is an infection that occurs as 
a result of a healthcare intervention. (1)Historically called a 
“nosocomial” infection, meaning “hospital acquired”, the term 
“healthcare” is now used in recognition that today much healthcare 
occurs outside a hospital. Examples of HAIs are bloodstream infections 
commonly caused by the presence of an intravenous device, or an 
infected surgical wound following a surgical procedure. Many HAIs 
result in significant morbidity and mortality. (2)It is estimated that in 
Europe and North America between 12-32% of HAI bloodstream 
infections result in death. (3) In Australia, it has been suggested that 
175,000 HAIs occur annually, (4) but the exact figure is unknown. 
Surveillance is defined as “the ongoing, systematic collection, 
analysis, and interpretation of health data essential to the planning, 
implementation, and evaluation of public health practice, closely 
integrated with the timely dissemination of these data to those who 
need to know”. (5) It is a fundamental component of modern 
healthcare, demonstrated by the recently released National Safety and 
Quality Health Service Standards for Australian Hospitals that include 
nineteen criteria on the prevention and control of HAIs, and 
specifically mandate HAI surveillance. (6)  
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By its very existence, infection prevention implies that HAIs are 
preventable. Whilst it is challenging to quantify the preventable 
proportion of HAIs, there is agreement that a significant proportion, 
and probably the majority of HAIs are preventable. (7, 8) 
The purpose of HAI surveillance is to provide quality data which can 
act as an effective monitoring and alert system. (9) The aim is to 
reduce the incidence of preventable HAIs. A successful HAI surveillance 
program must be epidemiologically robust, valid, accurate, timely, 
useful, consistent and practical. (5) 
Effective surveillance will deliver information to key stakeholders at 
all levels to inform decisions. The simple act of collecting HAI data will 
not reduce HAIs, (10) rather data must stimulate action and drive 
improvement. HAI surveillance systems establish a baseline rate of 
infection which can then be used to detect clusters or outbreaks, 
identify problems, evaluate prevention and control measures, generate 
hypotheses concerning risk factors, guide treatment and prevention 
strategies, make comparisons with other facilities, inform planning, 
and ultimately, reduce the incidence of HAIs. (11-14)  
Australia is one of the few developed countries without a national 
HAI surveillance program. Unlike the United State of America, (USA), 
the United Kingdom (UK) and many European countries who have 
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supported and maintained national HAI surveillance programs for 
decades, Australia lacks well structured processes to produce high 
quality national HAI data. In the UK and some state in the USA, 
reporting of some HAIs has been mandated by law. (15, 16) Such 
international programs enable research on the epidemiology of HAIs, 
which also leads to enhanced and refined surveillance processes 
improving the quality of HAI data now commonly reported in the public 
domain. (17, 18) In the USA, hospitals are financially penalised on the 
occurrence of events, many of them HAIs, which are deemed 
preventable. (19) 
Recent activity in Australia to develop national guides for the 
implementation of surveillance on Staphylococcus aureus bloodstream 
(SAB) infection, Clostridium difficile infection (CDI) and central line 
associated bloodstream infection (CLABSI), (20) is positive, but there is 
still much work to be done to improve our knowledge on the 
epidemiology of HAIs across Australia. 
The purpose of this paper is to review well established international 
HAI surveillance programs and their impact on HAI rates, provide an 
overview of current Australian HAI surveillance programs, and 
recommend a way forward to develop a national HAI surveillance 
program. This review focuses on surveillance of infections in large 
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acute public healthcare facilities, where the risk and consequences of 
infection is higher, due to the nature of the care that takes place. 
 
Methods 
 A review of current literature on national HAI surveillance programs 
was undertaken to identify existing national programs. The MEDLINE 
database from 1966 to 2013 was utilised by searching these key terms: 
cross infection, nosocomial infection, nosocomial infection rates, 
healthcare associated infection, healthcare associated infection rates, 
surveillance, infection prevention, infection control. Australian 
jurisdictional and national programs from overseas that were best 
described in the literature were then selected for review. To gain 
further information on international programs a review of program 
websites, surveillance manuals, annual reports and data reports 
(where available) was performed, and program representatives 
Germany, UK, Spain, Scotland and the Netherlands were directly 
contacted for clarification. For Australian surveillance activities, 
information was sourced from program websites and manuals, and 
representatives from each program were contacted for confirmation 
and clarification.  
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Results 
International HAI Surveillance Programs and Impact 
The longest running national HAI surveillance program is the Centers 
for Disease Control’s National Healthcare Safety Network (NHSN) in the 
USA. (21) Originally called National Nosocomial Infection Surveillance 
(NNIS) system, it commenced in 1970 with 62 hospitals voluntarily 
participating. (21) In 2005, the program expanded to include co-
existing healthcare worker exposure and renal dialysis surveillance 
programs to create the NHSN. (22) The definitions and methodology 
developed by the initial NNIS program have been largely adopted by 
many programs internationally. (18)  
In the USA, a review of HAI rates in hospitals participating in NNIS 
between 1990 and 1999 demonstrated decreases in urinary tract, 
respiratory tract and bloodstream infections monitored in ICUs. (23) 
Reductions in bloodstream infection rates varied from 31-44%. The 
authors acknowledge that other explanations, such as a national effort 
to reduce HAIs may have also influenced these results. (24) 
Other well described national HAI surveillance programs include the 
Krankenhaus-Infektions-Surveillance-System (KISS) in Germany, (25) 
the UK, (26) Spain(27, 28)France, (29) Scotland, (30)and the 
Netherlands. (31) 
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In Germany, Gastmeier demonstrated significant reductions in HAI 
of between 20-30% over a three year period in hospitals participating 
in the KISS program. Significant reductions of 24-57% in surgical site 
infections (SSI) have been demonstrated in the Netherlands and 
Denmark following the introduction of national surveillance. (32) A 
review of SSI in France over six years following the introduction of 
surveillance demonstrated a 30% reduction in the first three years with 
an ongoing decrease in infection rates over the next three years. (29)  
In the Netherlands, SSI surveillance commenced in 1996 as a 
component of the new national HAI surveillance program “PREZIES”. 
Geubbels et al claim that surveillance led to a decrease in risk of SSI of 
31% when measured four years from the introduction of the program, 
and of 57% in its fifth year. (33) 
 
Current issues with international programs 
A recent review of international surveillance programs noted that 
despite being similarly structured and following international 
recommendations and standardised definitions, widespread variation 
existed between programs. (34) Grammatico-Guillon et al identified 
variation in data collection methods and quality due to differences in 
category of staff performing surveillance, variable data sources, 
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prospective and retrospective data collection, and the presence of 
routine post discharge surveillance. (34)  It was also noted that 
validation of data did not occur on a regular basis. (34)  
Traditional surveillance methods are time consuming, application of 
definitions is subject to interpretation and identification of cases is 
dependent on effort. (35) Infection prevention staff spend up to 45% of 
their time undertaking surveillance. (36) As Perl and Chaiwarth note, 
essential to the future of HAI surveillance is the integration of rapidly 
developing surveillance technologies. Electronic HAI surveillance 
systems, when compared to traditional surveillance methods, can 
reduce time spent by up to 65%, and improved sensitivity or specificity 
can be demonstrated. (13) Recent studies have highlighted the 
advantages of using modern technology such as increased accuracy of 
hospital rankings when computer algorithms are used. (37, 38) 
Attempts have been made to use administrative code data (ACD) to 
identify HAIs, but a recent systematic review found the use of ACD 
continues to demonstrate only moderate sensitivity. (3) Goto et al 
recommend that ACD may be useful as a factor within an algorithm, 
but should not be used as the primary case finding method. (3)  
The use of automated technology and electronic data as an aid to 
traditional HAI surveillance methods is well described. (39) Automated 
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systems ensure consistent application of surveillance definitions, 
significantly reduce the burden of data management and provide 
improved sensitivity and specificity. (39)  
The current situation in Australia 
 Of Australia's eight States and Territories, several States 
implemented HAI surveillance programs during the 1990s and 2000s, 
using infection definitions based on those developed by NNIS. (40-43)  
In December 2008 the Australian Health Ministers’ Conference 
endorsed jurisdictional level surveillance of SAB and CDI. This was 
followed in 2009 by further endorsement of the Australian Commission 
on Safety and Quality in Health Care (ASQHC) recommendation that 
hospitals routinely monitor SAB and CDI.  
A comparison of surveillance components considered mandatory in 
existing state wide programs is demonstrated in Table 1. There is 
consistency in Intensive Care Unit CLABSI, and SSI surveillance of knee 
and hip replacement surgery across the larger States.  However there 
is inconsistency between mandatory surveillance components, 
definitions, and post-discharge surveillance. Not included in the table 
due to the large degree of variation, is inconsistency identified with 
regards to multi-resistant, or significant, organism surveillance. Whilst 
some States report multi-resistant, or significant, organism 
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surveillance programs, others do not. Peculiar to each jurisdiction is 
the intensity of surveillance undertaken with respect to the type of 
organism, infection or colonisation, site, hospital onset or healthcare 
associated, and requirements for the data to be notified at a State 
level. In Tasmania and Western Australia, notification of SAB is 
mandated. 
Anecdotally, it is reported that many hospitals, networks or regions 
undertake HAI surveillance above and beyond the mandatory 
requirements of their jurisdiction. Examples include individual 
hospitals performing targeted surveillance in unique, high risk 
populations, or in response to perceived problems. The extent of this 
activity and the quality of data is unknown. 
 
Discussion 
This review has identified well established international HAI 
surveillance programs with evidence of a reduction of HAI rates, whilst 
highlighting some of the major gaps in HAI surveillance activities 
undertaken across Australia. 
The evolution of HAI surveillance programs in Australia has been 
fragmented. Whilst some of the jurisdictional programs are now well 
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established and embedded into routine healthcare safety and quality 
processes, it could be argued that without clear national direction, the 
programs evolved in a competitive environment. This has resulted in 
variation among methods, (44) duplication of effort and a limited 
ability to collate and analyse data at a national level. Potential 
differences between programs deserving of further research include 
level of training of those involved in HAI surveillance, data analysis and 
reporting. 
Unlike international programs, there is a lack of evidence 
demonstrating the effect of these state wide programs on HAI rates 
over time, although two of these programs have published validation 
studies. (43, 45-47) 
Current ASQHC strategies such as the National Surveillance Initiative 
(20) have promoted and supported increased jurisdictional 
collaboration. The development of national definitions for SAB and CDI 
have been followed by identifiable hospital SAB data regularly 
published on the MyHospitals website. (48) Whilst concerns regarding 
the validity and lack of risk adjustment (49-51) need to be addressed, 
the work of the ACSQHC HAI program continues to provide direction for 
further national HAI surveillance activity. The recently completed 
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ACSQHC report on Antimicrobial Resistance and Antibiotic Usage adds 
to the drive for better national HAI surveillance processes. (52) 
The Benefits of an Australian HAI surveillance program 
As key stakeholders, consumers, healthcare workers and policy 
makers will all benefit from a well constructed national HAI 
surveillance program. Consumers clearly stand to gain from improved 
quality of care resulting in reduced risk of acquiring a HAI.  Healthcare 
workers will benefit from improved efficiency in surveillance processes 
that could relieve the current burden of data collection, and the 
development of national education programs for those undertaking HAI 
surveillance to be uniformly accessible across Australia. The ready 
availability of benchmarking data will assist hospitals in appropriately 
allocating resources to infection prevention activities. Meaningful 
national comparisons of HAI rates by hospital size, type, specialty and 
potentially by specific patient risk factors will provide important 
contextual data across Australia. A comprehensive HAI surveillance 
program will provide analysis and interpretation of data, and drive 
investigation into unusual findings. This will lead to a sharing of 
information and through informed policy making, will ultimately 
benefit patient care. 
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The ability to describe the epidemiology of HAIs will improve our 
understanding of the difference between populations. Detailed data 
will enable the identification of problem areas that may require more 
infection prevention resources, and similarly highlight successful 
interventions which could act as role models and inform policy on 
State and national infection prevention initiatives. It will provide the 
foundation for local research initiatives to improve the safety and 
quality of healthcare to patients. 
Where to from here? 
In 2010, major infection prevention bodies including the Association 
for Professionals in Infection Control and Epidemiology, the Society for 
Healthcare Epidemiology of America, the Infectious Diseases Society of 
America, and the Centers for Disease Control and Prevention proposed 
four pillars for the elimination of HAIs, the fourth of which was “data 
to target prevention efforts and measure progress”. (53) To deliver 
timely and high quality data, they recommended“(1) reshaping 
standard definitions and surveillance methods to fit the new, emerging 
information system paradigms (e.g. electronic health information 
records and data mining); (2) creating national and global data 
standards for key HAI prevention metrics; and (3) creating or refining 
the data analysis and presentation tools available to prevention 
18 
experts, clinicians, and policy makers at the local, state, national, and 
international levels.”(53) These will provide valuable direction for a 
national HAI program in Australia.  
There is much to be done in identifying a framework for a national 
surveillance program, and the potential is exciting. First, we must take 
stock of the current situation in Australia to understand precisely the 
what, how and why of HAI surveillance currently being undertaken. To 
clearly identify, measure and describe exactly how much variation 
exists between hospitals and States and how this influences outcomes 
is necessary to inform future endeavours. Information requirements 
need to be balanced against available resources and it is possible 
current processes already exist which may be suitable to be extended 
into the national arena, and that better use of current data may be 
achievable. Although SAB data is currently being reported publicly, it is 
important that the data is validated and appropriately risk adjusted for 
meaningful comparisons to be made. Further, a meaningful way to 
report national CDI data that is currently collected needs to be 
identified. 
Second, resources, skill level and experience of those involved in 
current HAI surveillance will influence the quality of the program, and 
an understanding of the ideal mix of these characteristics is essential.  
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Third, we must explore the use of technology as an aid to efficient 
HAI surveillance processes. Efficient data collection processes remain 
elusive. Current manual data collection methods are unsustainable and 
impede wider surveillance activity, so it is essential that the inclusion 
of automated electronic surveillance systems be considered. Existing 
data that is readily accessible may inform efforts to identify an agreed 
minimum level data set for some HAIs.  
Fourth, we must identify the key components of successful 
programs. No program will be perfect, but there are decades of lessons 
to be learnt from our colleagues across the world. Similarly, we must 
also draw upon the experience of our local experts and engage all key 
stakeholders to identify the barriers and enablers for national HAI 
surveillance. For example, a model mapping out the influences on 
reliable and valid HAI data has recently been developed by Australian 
researchers. (54) 
 
Conclusion 
Evidence clearly demonstrates that national HAI surveillance 
programs provide meaningful, reliable and valid data that ultimately 
reduce the incidence of HAIs. Whilst Australian jurisdictions continue 
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to conduct disparate HAI surveillance programs, utility of data at a 
national level remains limited. Centrally coordinated international HAI 
surveillance programs can act as a model for an Australian system, 
which can be further enhanced through the use of technology. The lack 
of a national program in Australia presents a unique opportunity to 
construct a HAI surveillance program based on the best available 
evidence. 
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1 
Table 1. Comparison of mandatory healthcare associated infection surveillance components in acute care public facilities by state 
All states and territories in Australia undertake surveillance for Staphylococcus aureus bloodstream (SAB) infection and Clostridium difficile infection (CDI). 
✔, surveillance performed; , surveillance not performed; 1, with modifications; 2, including neonatal intensive care unit (NICU); 3, NICU only; 4, if >50 
procedures per year; 5, Royal Women’s hospitals and Women’s Mercy Hospital only; 6, infections only; ICU, intensive care unit; MRSA, methicillin-
resistant Staphylococcus aureus; MRAB, multi-resistant Acinetobacter; NHSN, National Health and Safety Network; BSI, bloodstream infection; NA, not 
applicable. 
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NSW 
Healthcare Associated 
Infections Program  ✔  ✔  ✔  ✔  ✔  ✔  ✖  ✖  ✔ (1) ✖  ✖  ✖ 
QLD 
Centre for Health Related 
Infection Surveillance and 
Prevention (CHRISP) 
(medium to large hospitals) 
✔  ✔  ✔  ✔  ✔  ✔  ✖  ✔A  ✔ (1) ✔  ✔  ✔ 
2 
SA 
South Australian HAI 
surveillance program  ✔  ✔  ✔  ✖  ✖  ✖  ✖  ✖  ✔  ✔  ✖  ✔ 
TAS 
Tasmanian Infection 
Prevention and Control Unit 
(TIPCU) 
✖  ✖  ✖  ✖  ✖  ✖  ✖  ✖  NA  ✖  ✖  ✖ 
VIC 
Victorian Healthcare 
Associated Infection 
Surveillance System 
(VICNISS)  
✔ (2)  ✖  ✖  ✔  ✔ (4) ✔ (4)  ✔ (5) ✔A  ✔  ✖  ✖  ✖ 
WA 
Healthcare Infection 
Surveillance Western 
Australia (HISWA) 
✔  ✔ (6) ✔ (6) ✖  ✔  ✔  ✖  ✔A  ✔ (1) ✔  ✔  ✖ 
	
	
A	Optional	
B	Includes	colonisation	and	infection	
 
 
